These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36941616)

  • 1. Anti-malarial drug use, appropriateness and associated factors among children under-five with febrile illnesses presenting to a tertiary health facility: a cross sectional study.
    Nyeko R; Otim F; Obiya EM; Abala C
    Malar J; 2023 Mar; 22(1):103. PubMed ID: 36941616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-hospital exposures to antibiotics among children presenting with fever in northern Uganda: a facility-based cross-sectional study.
    Nyeko R; Otim F; Obiya EM; Abala C
    BMC Pediatr; 2022 Jun; 22(1):322. PubMed ID: 35650548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare provider and drug dispenser knowledge and adherence to guidelines for the case management of malaria in pregnancy in the context of multiple first-line artemisinin-based combination therapy in western Kenya.
    Osoro CB; Dellicour S; Ochodo E; Young T; Ter Kuile F; Gutman JR; Hill J
    Malar J; 2023 Sep; 22(1):262. PubMed ID: 37679753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study.
    Ewing VL; Terlouw DJ; Kapinda A; Pace C; Richards E; Tolhurst R; Lalloo DG
    Malar J; 2015 Jan; 14():13. PubMed ID: 25605477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya.
    Watsierah CA; Onyango RO; Ombaka JH; Abong'o BO; Ouma C
    Malar J; 2012 Dec; 11():436. PubMed ID: 23273046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites.
    Ajayi IO; Browne EN; Garshong B; Bateganya F; Yusuf B; Agyei-Baffour P; Doamekpor L; Balyeku A; Munguti K; Cousens S; Pagnoni F
    Malar J; 2008 Jan; 7():6. PubMed ID: 18182114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso.
    Hien D; Kaboré JMT; Siribié M; Soulama I; Barry N; Baguiya A; Tiono AB; Tchouatieu AM; Sirima SB
    Malar J; 2022 Jun; 21(1):202. PubMed ID: 35761273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, southeast Nigeria: implications for malaria treatment policy.
    Ezenduka CC; Ogbonna BO; Ekwunife OI; Okonta MJ; Esimone CO
    Malar J; 2014 Jun; 13():243. PubMed ID: 24961280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copayment mechanism in selected districts of Uganda: Availability, market share and price of quality assured artemisinin-based combination therapies in private drug outlets.
    Ocan M; Nambatya W; Otike C; Nakalembe L; Nsobya S
    PLoS One; 2024; 19(3):e0295198. PubMed ID: 38536824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
    Dodoo AN; Fogg C; Asiimwe A; Nartey ET; Kodua A; Tenkorang O; Ofori-Adjei D
    Malar J; 2009 Jan; 8():2. PubMed ID: 19123926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria diagnostic and treatment practices for febrile children under 5 years at two general hospitals in Karamoja, a high transmission setting in Uganda.
    Zalwango JF; Nankabirwa JI; Kitutu FE; Akunzirwe R; Buhuguru R; Rokani JB; Ssendikwanawa E; Kiguli S; Arinaitwe E; Kalyango JN
    Malar J; 2022 Nov; 21(1):312. PubMed ID: 36329454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-malarial prescription practices among outpatients with laboratory-confirmed malaria in the setting of a health facility-based sentinel site surveillance system in Uganda.
    Sears D; Kigozi R; Mpimbaza A; Kakeeto S; Sserwanga A; Staedke SG; Chang M; Kapella BK; Rubahika D; Kamya MR; Dorsey G
    Malar J; 2013 Jul; 12():252. PubMed ID: 23870515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescriber practices and patient adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria in Guinea, 2016.
    Camara A; Moriarty LF; Guilavogui T; Diakité PS; Zoumanigui JS; Sidibé S; Bah I; Kaba I; Kourouma D; Zoumanigui K; Plucinski M
    Malar J; 2019 Jan; 18(1):23. PubMed ID: 30683128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo.
    Pembet Singana B; Casimiro PN; Matondo Diassivi B; Kobawila SC; Youndouka JM; Basco LK; Ringwald P; Briolant S; Ndounga M
    Malar J; 2022 May; 21(1):137. PubMed ID: 35501861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa.
    Ajayi IO; Browne EN; Bateganya F; Yar D; Happi C; Falade CO; Gbotosho GO; Yusuf B; Boateng S; Mugittu K; Cousens S; Nanyunja M; Pagnoni F
    Malar J; 2008 Sep; 7():190. PubMed ID: 18822170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receipt of antimalarials among children aged 6-59 months in Nigeria from 2010 to 2021.
    Olisakwe SC; Thwing J; Dionne JA; Irvin R; Kachur PS; Bruxvoort KJ
    Malar J; 2024 Aug; 23(1):249. PubMed ID: 39160583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of anti-malarial drug treatment among pregnant women in Uganda.
    Sangaré LR; Weiss NS; Brentlinger PE; Richardson BA; Staedke SG; Kiwuwa MS; Stergachis A
    Malar J; 2011 Jun; 10():152. PubMed ID: 21645402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of inappropriate prescription of artemisinin and anti-malarial injections to febrile outpatients, a cross-sectional analytic survey in the Greater Accra region, Ghana.
    Bonful HA; Awua AK; Adjuik M; Tsekpetse D; Adanu RMK; Nortey PA; Ankomah A; Koram KA
    Malar J; 2019 Sep; 18(1):331. PubMed ID: 31558149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.